Sydney Lepkin

Although most people taking these drugs say they have some insurance coverage for them, more than half say the drugs are difficult to afford.

KFF conducted the poll between October 27th and November 2nd.

Sydney Lepkin, NPR News.

I'm Lakshmi Singh, NPR News.

Normally, companies can't advertise a drug to treat a condition it hasn't been FDA-approved to treat.

But sponsored search results online aren't regulated the way television ads are.

Daniel Eisenkraft-Klein and his colleagues at Harvard Medical School looked at two years of paid search results for Ozempic.

According to a study published in JAMA Network Open, 11% of paid search phrases contain the word weight, even though Osempic is only approved to treat type 2 diabetes.

Novo Nordisk says its paid search approach is standard and in compliance with U.S.

laws and regulations.

Sydney Lepkin, NPR News.

President Trump announced drugmaker EMD Sirono has agreed to lower prices for its fertility drugs, like Gonal-F, sold directly to patients not using their insurance.

All told, the company's IVF drugs will be offered at an 84 percent discount.

But the deal doesn't include EMD Sirono's other drugs for things like cancer and multiple sclerosis.

The announcement is part of the president's push to bring U.S.

drug prices in line with those paid in other countries, an effort he calls most favored nation pricing.

and it follows his campaign promise to make IVF more affordable.

A typical IVF cycle can cost as much as $30,000, and while drugs are part of that, they aren't the majority of the total cost.

For its part, EMD Sirono will get an expedited FDA review of a new drug and relief from certain tariffs.

Sydney Lepkin, NPR News.